Synthetic biology is booming
They print DNA, design proteins, and sell pipetting robots. That’s traditionally known as back-end technology, but now synthetic biology’s hottest companies are pitching engineered microbes as a source for everything from gut drugs to fertilizer.
“Fundamentally, it’s recombinant DNA technology, it’s biotechnology, but it has a new name: synthetic biology,” said John Cumbers, the industry’s informal spokesman and CEO of the industry network that’s also known as SynBioBeta.
So far this year, synthetic biology companies collectively raised $1.9 billion, up 74 percent over last year’s full-year total, STAT’s Rebecca Robbins reports from the group's annual conference in San Francisco. But there are some caveats, about money — and about the science. Plus some eye-catching slogans.
Read more.
“Fundamentally, it’s recombinant DNA technology, it’s biotechnology, but it has a new name: synthetic biology,” said John Cumbers, the industry’s informal spokesman and CEO of the industry network that’s also known as SynBioBeta.
So far this year, synthetic biology companies collectively raised $1.9 billion, up 74 percent over last year’s full-year total, STAT’s Rebecca Robbins reports from the group's annual conference in San Francisco. But there are some caveats, about money — and about the science. Plus some eye-catching slogans.
Read more.
No hay comentarios:
Publicar un comentario